INTRODUCTION: Based on the clinical history, paroxysmal atrial fibrillation (PAF) may be classified as vagotonic, adrenergic, or random. It is unclear whether pulmonary vein (PV) isolation is equally effective for these types of PAF. METHODS AND RESULTS: Segmental ostial ablation to isolate the PVs was performed in 188 consecutive patients (mean age 53 +/- 12 years) with PAF. Based on the clinical history, PAF was classified as random in 136 patients (72%), adrenergic in 30 (16%), and vagotonic in 22 (12%). Three or four PVs were targeted for isolation in all patients, and successful isolation was achieved in 96% of targeted PVs. At 1-year follow-up, 69% of patients with random AF, 83% of patients with adrenergic AF, and 50% of patients with vagotonic AF were free from recurrent episodes of AF in the absence of any antiarrhythmic drug therapy. Vagotonic AF was an independent clinical predictor of recurrent AF (P = 0.03). CONCLUSION: PV isolation has a lower efficacy in patients with vagotonic PAF than in patients with adrenergic or random episodes of PAF, suggesting that the PVs less often play an important role in vagotonic PAF.
INTRODUCTION: Based on the clinical history, paroxysmal atrial fibrillation (PAF) may be classified as vagotonic, adrenergic, or random. It is unclear whether pulmonary vein (PV) isolation is equally effective for these types of PAF. METHODS AND RESULTS: Segmental ostial ablation to isolate the PVs was performed in 188 consecutive patients (mean age 53 +/- 12 years) with PAF. Based on the clinical history, PAF was classified as random in 136 patients (72%), adrenergic in 30 (16%), and vagotonic in 22 (12%). Three or four PVs were targeted for isolation in all patients, and successful isolation was achieved in 96% of targeted PVs. At 1-year follow-up, 69% of patients with random AF, 83% of patients with adrenergic AF, and 50% of patients with vagotonic AF were free from recurrent episodes of AF in the absence of any antiarrhythmic drug therapy. Vagotonic AF was an independent clinical predictor of recurrent AF (P = 0.03). CONCLUSION: PV isolation has a lower efficacy in patients with vagotonic PAF than in patients with adrenergic or random episodes of PAF, suggesting that the PVs less often play an important role in vagotonic PAF.
Authors: Aamir Cheema; Chandrasekhar R Vasamreddy; Darshan Dalal; Joseph E Marine; Jun Dong; Charles A Henrikson; David Spragg; Alan Cheng; Saman Nazarian; Sunil Sinha; Henry Halperin; Ronald Berger; Hugh Calkins Journal: J Interv Card Electrophysiol Date: 2006-08-05 Impact factor: 1.900
Authors: Scott A Bernstein; Brian Wong; Carolina Vasquez; Stuart P Rosenberg; Ryan Rooke; Laura M Kuznekoff; Joshua M Lader; Vanessa M Mahoney; Tatyana Budylin; Marie Älvstrand; Tammy Rakowski-Anderson; Rupinder Bharmi; Riddhi Shah; Steven Fowler; Douglas Holmes; Taraneh G Farazi; Larry A Chinitz; Gregory E Morley Journal: Heart Rhythm Date: 2012-05-01 Impact factor: 6.343
Authors: Raija Jurkko; Heikki Väänänen; Ville Mäntynen; Jouni Kuusisto; Markku Mäkijärvi; Lauri Toivonen Journal: Ann Noninvasive Electrocardiol Date: 2008-10 Impact factor: 1.468
Authors: Naiara Calvo; Lluís Mont; David Tamborero; Antonio Berruezo; Graziana Viola; Eduard Guasch; Mercè Nadal; David Andreu; Barbara Vidal; Marta Sitges; Josep Brugada Journal: Europace Date: 2010-01 Impact factor: 5.214